Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mabpharm Limited ( (HK:2181) ) has provided an update.
Mabpharm Limited has announced that its board of directors will meet on August 28, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will determine the company’s financial performance and could impact its market positioning and stakeholder interests.
More about Mabpharm Limited
Mabpharm Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and production of biopharmaceutical products.
Average Trading Volume: 530,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.72B
For a thorough assessment of 2181 stock, go to TipRanks’ Stock Analysis page.